1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
610CBC9FC2CEFD85285256EB000608527
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/keys-to-recruiting-and-preparing-study-sites-for-clinical-trials?opendocument
18
19opendocument
2018.207.134.98
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Clinical Operations Clinical Trial Investigators

Keys to Recruiting and Preparing Study Sites for Clinical Trials

DB Image

ID: 4672


Features:

Graphics


Pages/Slides: 21


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • BROWSE SELECTED PAGES
  • SPECIAL OFFER
Study Overview

More and more clinical studies are in the development pipeline, and study sites cannot keep up with this demand. Pharmaceutical companies need to be especially savvy in their messages to prospective study sites about why it is in their interest to participate in their study. Pharmaceutical companies can use this information to generate as much interest as possible in a study so they can choose among a greater number of interested investigators. This 21-page document details the way top pharmaceutical companies create well-defined site communications teams.

Key Topics

  • scientific benefits of participating in a study
  • patient benefits of participating in a study
  • disclosure of protocol requirements
  • working with contract organizations or sponsoring companies
  • using investigator meetings to prepare study sites


Sample Best Practices
  • Create a site communications team with specific areas of expertise and roles to communicate effectively and efficiently with study sites
    *One executive said that there is often more cooperation in studies when the pharmaceutical company works directly with study sites.
  • Use a variety of channels to communicate customized messages to investigators
    *One company ascertained which channels were more effective than others with particular investigators.
  • Use investigator meetings to motivate and energize participating study sites.
    *According to an interviewed executive at a large pharamceutical company, the study sites appreciate receiving them not only because the information helps them catch up with what has happened before, but because they feel part of a greater community rallying around an exciting scientific program.
Methodology
This research originated from a Best Practices, LLC consulting project.

Industries Profiled:
Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Health Care; Research; Professional Services


Companies Profiled:
AstraZeneca; Sanofi-aventis; Bayer; Bristol-Myers Squibb; Eli Lilly and Company; GlaxoSmithKline; Pfizer; Roche; Trimeris; aaiPharma; America's Doctor; BBK Healthcare; Covance; Health Decisions; PPD

Browse Selected Pages
Click on an image below to see the full PDF version

Cover Page
Cover Page
Sample Page 1
Sample Page 1
Sample Page 2
Sample Page 2

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.